ALLOX raises $10.5M seed

◆ Amount

$10.5M

◆ Announced

29 Oct 2026

◆ Company

◆ Source

◆ The Round

ALLOX raised $10.5M in seed funding, announced on 29 October 2026, led by Asabys, with participation from CDTI, Institut Català de Finances (ICF). The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About ALLOX

Biotechnology company developing a drug discovery platform combining high-throughput genetics, experimental biology and artificial intelligence to identify therapeutic opportunities for small-molecule therapeutics. ALLOX is based in Spain and currently at seed stage, operating in Biotech, Drug Discovery.

◆ Investors

◆ Investing funds on Raise

• Asabys Partners

◆ Market context

Asabys Partners is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links ALLOX's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market